Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of ($0.89), $0.05 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.92 billion.

GUIDANCE:

Oscar Health Inc. sees FY2025 revenue of $12-12.2 billion, versus the consensus of $12.01 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.